Draft Guidance Recommends Oncology Trials Use Wide Range of Doses
March 1, 2023
Oncology drug trials should investigate a wide range of doses in as widely varied a population as possible rather than immediately titrating patients up to the maximum tolerated dose (MTD), the FDA said in a new draft guidance.